We raise applications for Yokohama-shi trial grant in 2024.

This time, in the GX / decarbonization and health / medical fields using biotechnology, research results and ideas for city startups, small and medium-sized enterprises, universities, research institutions, etc. aiming to commercialize new products and technologies. We raise applications of "Yokohama-shi trial grant" which we can utilize for development of prototype to materialize.
In fiscal 2024, we will focus on research and development on themes related to GX and decarbonization fields using biotechnology, rare diseases, and cancer fields using biotechnology, and will focus on these research and development.